Department of Advanced Green Energy and Environment, Handong Global University, Pohang, Gyeongbuk, 37554, South Korea.
Korea Food Research Institute, Wanju, 55365, South Korea.
Probiotics Antimicrob Proteins. 2021 Jun;13(3):677-697. doi: 10.1007/s12602-020-09720-0. Epub 2020 Nov 14.
Lactobacillus plantarum KC28 showed a beneficial (anti-obesity) effect in a diet-induced obese (DIO) C57BL/6 murine model receiving an intermediate high-fat diet (IF). This diet was selected for probiotic studies by prior comparisons of different combinations of basic (carbohydrate, protein and fat) components for optimized induction of dietary obesity in a murine model. Prior selection of Lact. plantarum strain KC28 was based on different physiological tests for safety and functionality including cell line adhesion and anti-adipogenic activity. The strain was administered at 5.0 × 10 CFU/mouse/day to the DIO mice (control mice received a normal diet). The anti-obesity effect of KC28 and the well-known probiotic strains Lact. rhamnosus GG (LGG) and Lact. plantarum 299v was assessed over 12 weeks. Xenical served as anti-obesity control. The high-fat diet groups receiving strains KC28 and LGG and the control Xenical group showed significant weight loss and notable changes in some obesity-related biomarkers in the liver (significant up-regulation of PGC1-α and CPT1-α only by KC28; p < 0.05) and mesenteric adipose tissue (significant down-regulation of ACOX-1, PPAR-γ, and FAS; KC28 p < 0.001 for PPAR-γ and FAS), compared with the IF control. Favourable changes in the studied biomarkers suggest a similar beneficial influence of Lact. plantarum KC28 on the alleviation of obesity comparable with that of the two well-studied probiotic strains, LGG and 299v. This probably resulted from a modulation in the cecal microbiota of the IF group by either probiotic strain, yet in a different manner, showing a highly significant increase in the families Desulfovibrionaceae and Lactobacillaceae only in the group receiving Lact. plantarum KC28.
植物乳杆菌 KC28 在接受中间高脂肪饮食 (IF) 的饮食诱导肥胖 (DIO) C57BL/6 小鼠模型中显示出有益的(抗肥胖)作用。这种饮食是通过先前对不同基本(碳水化合物、蛋白质和脂肪)成分组合的比较选择的,用于在小鼠模型中优化诱导饮食肥胖。先前选择植物乳杆菌 KC28 是基于不同的生理测试,包括细胞系粘附和抗脂肪生成活性,以确保安全性和功能性。该菌株以 5.0×10 CFU/小鼠/天的剂量施用于 DIO 小鼠(对照小鼠接受正常饮食)。KC28 和著名的益生菌菌株鼠李糖乳杆菌 GG (LGG) 和植物乳杆菌 299v 的抗肥胖作用在 12 周内进行了评估。Xenical 作为抗肥胖对照。接受 KC28 和 LGG 菌株以及对照 Xenical 组的高脂肪饮食组显示体重显著减轻,肝脏中一些与肥胖相关的生物标志物发生显著变化(仅 KC28 显著上调 PGC1-α 和 CPT1-α;p<0.05)和肠系膜脂肪组织(ACOX-1、PPAR-γ 和 FAS 的显著下调;KC28 对 PPAR-γ 和 FAS 的下调作用均 p<0.001),与 IF 对照组相比。研究生物标志物的有利变化表明,植物乳杆菌 KC28 对缓解肥胖的有益影响与两种经过充分研究的益生菌菌株 LGG 和 299v 相似。这可能是由于两种益生菌菌株中的任何一种都对 IF 组的盲肠微生物群进行了调节,但方式不同,仅在接受植物乳杆菌 KC28 的组中观察到脱硫弧菌科和乳杆菌科的家族显著增加。